Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine

Journal of Headache and Pain

Volumn 8, Issue 5, 2007, Pages 283-288

  Guidotti, Mario ^a   Mauri, Michela ^a   Barrilà, Caterina ^a   Guidotti, Francesca ^a   Belloni, Carlo ^a  

^a VALDUCE HOSPITAL   (Italy)

Author keywords

Frovatriptan; Menstrual migraine; Menstrually related migraine; Naproxen sodium; Transdermal oestrogens; True menstrual migraine

Indexed keywords

ESTROGEN; FROVATRIPTAN; NAPROXEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MENSTRUAL MIGRAINE; OPEN STUDY; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBAZOLES; ESTROGENS; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIGRAINE DISORDERS; NAPROXEN; PAIN MEASUREMENT; PILOT PROJECTS; RECURRENCE; SEROTONIN AGONISTS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 36749019731     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-007-0417-4     Document Type: Article

References (24)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349
2. Breslau N, Rasmussen BK (2001) The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology 56[6 Suppl 1]:4-12
3. Brandes JL (2006) The influence of estrogen on migraine: A systematic review. JAMA 295:1824-1830
4. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24[Suppl. 1]:1-160
5. Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C et al (2004) Characteristics of menstrual and non-menstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 24:707-716
6. Allais G, Benedetto C (2004) Update on menstrual migraine: From clinical aspects to therapeutical strategies. Neurol Sci 25[Suppl 3]:229-231
7. Mannix LK (2003) Management of menstrual migraine. Neurologist 9:207-213
8. Ashkenazi A, Silberstein SD (2006) Hormone-related headache: pathophysiology and treatment. CNS Drugs 20:125-141
9. MacGregor A (2000) Migraine associated with menstruation. Funct Neurol 15[Suppl 3]:143-153
10. Martin V (2007) Targeted treatment strategies for menstrual migraine. J Fam Pract 56:13-22
11. Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63:261-269
12. Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG et al (2001) Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, double-blind, placebo-controlled study. Headache 41:248-256
13. Newman LC, Lipton RB, Lay CL, Solomon S (1998) A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 51:307-309
14. Moschiano F, Allais G, Grazzi L, Usai S, Benedetto C, D'Amico D et al (2005) Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 26[Suppl 2]:162-166
15. Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C (2005) Advanced strategies of short-term prophylaxis in menstrual migraine: State of the art and prospects. Neurol Sci 26[Suppl 2]:125-129
16. Geraud G, Spierings EL, Keywood C (2002) Tolerability and safety of frovatriptan with short-and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 42[Suppl 2]:93-99
17. Belsey EM, Farley TM (1988) The analysis of menstrual bleeding patterns: a review. Contraception 38:129-156
18. Smits MG, van der Meer YG, Pfeil JP, Rijnierse JJ, Vos AJ (1994) Perimenstrual migraine: Effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 34:103-106
19. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G (1990) Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study. Headache 30:705-709
20. Pradalier A, Vincent D, Beaulieu P, Baudesson G, Launay J (1994) Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In: Rose C, ed. New Advances in Headache Research: 4. London: Smith-Gordon 129-132
21. Pfaffenrath VL (1993) Efficacy and safety of percutaneous estradiol vs. placebo in menstrual migraine. Cephalalgia 13[suppl]:244-247
22. Smits MG, van der Meer YG, Pfeil JP, Rijnierse JJ, Vos AJ (1994) Perimenstrual migraine: Effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 34:103-106
23. MacGregor EA (2004) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3:354-361
24. Nappi RE, Sances G, Brundu B, De Taddei S, Sommacal A, Ghiotto N et al (2005) Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Hum Reprod 20:3423-3428